Overview

Comparison of Metoclopramide and Ibuprofen for the Treatment of Acute Mountain Sickness

Status:
Completed
Trial end date:
2017-03-30
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the efficacy of metoclopramide in relieving the symptoms of Acute Mountain Sickness (AMS). It is our hypothesis that the combined antiemetic and analgesic effects of metoclopramide (which has been study-proven to be effective in relieving symptoms of migraine headache) will prove to be more efficacious in relieving symptoms of acute mountain sickness than the standard, previously-studied analgesic medication, ibuprofen.
Phase:
N/A
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Ibuprofen
Metoclopramide